What does CUSIP 40637H109 represent in this 13F holders report?

CUSIP 40637H109 is the security identifier for HALO - HALOZYME THERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in Q4 2017?

196 institutional investors reported HALO - HALOZYME THERAPEUTICS, INC. - Common Stock for Q4 2017. Use the holders table for investor-level position and value details.

HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

CUSIP: 40637H109

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class: Equity / Common Stock
Shares outstanding: 118,494,184
Total 13F shares: 122,499,248
Share change: +905,481
Total reported value: $2,482,081,024
Put/Call ratio: 48%
Price per share: $20.26
Number of holders: 196
Value change: +$20,859,736
Number of buys: 106
Number of sells: 67

Quarterly Holders Quick Answers

What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2018
Previous quarter: Q3 2017

Recent filing periods for CUSIP 40637H109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Third Security, LLC	13F	Company	15%	17,592,771	$305,586,000	—	30 Sep 2017	13F
BlackRock Finance, Inc.	13F	Company	10%	12,164,375	$211,295,000	—	30 Sep 2017	13F
IRIDIAN ASSET MANAGEMENT LLC/CT	13F	Company	8.4%	10,005,952	$173,803,000	—	30 Sep 2017	13F
VANGUARD GROUP INC	13F	Company	8.4%	9,991,405	$173,550,000	—	30 Sep 2017	13F
BB BIOTECH AG	13F	Company	7.3%	8,626,051	$149,835,000	—	30 Sep 2017	13F
First Eagle Investment Management, LLC	13F	Company	5.4%	6,444,981	$111,949,000	—	30 Sep 2017	13F
FMR LLC	13F	Company	4.2%	4,968,581	$86,304,000	—	30 Sep 2017	13F
Invesco Ltd.	13F	Company	3.7%	4,426,226	$76,883,000	—	30 Sep 2017	13F
SENZAR ASSET MANAGEMENT, LLC	13F	Company	3.2%	3,830,190	$66,531,000	—	30 Sep 2017	13F
STATE STREET CORP	13F	Company	3.1%	3,678,698	$63,900,000	—	30 Sep 2017	13F
JPMORGAN CHASE & CO	13F	Company	2.4%	2,868,670	$49,915,000	—	30 Sep 2017	13F
SNYDER CAPITAL MANAGEMENT L P	13F	Company	2.1%	2,466,684	$42,846,000	—	30 Sep 2017	13F
MSD Partners, L.P.	13F	Company	1.9%	2,245,000	$38,996,000	—	30 Sep 2017	13F
Bank of New York Mellon Corp	13F	Company	1.8%	2,099,163	$36,462,000	—	30 Sep 2017	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	1.6%	1,888,426	$32,802,000	—	30 Sep 2017	13F
NORTHERN TRUST CORP	13F	Company	1.4%	1,710,107	$29,704,000	—	30 Sep 2017	13F
BAKER BROS. ADVISORS LP	13F	Company	1.3%	1,581,424	$27,469,000	—	30 Sep 2017	13F
Artisan Partners Limited Partnership	13F	Company	1.2%	1,435,886	$24,941,000	—	30 Sep 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.97%	1,153,116	$20,028,000	—	30 Sep 2017	13F
OppenheimerFunds, Inc.	13F	Company	0.85%	1,002,493	$17,413,000	—	30 Sep 2017	13F
NORGES BANK	13F	Company	0.84%	995,008	$17,283,000	—	30 Sep 2017	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.72%	856,579	$14,879,000	—	30 Sep 2017	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.72%	856,575	$14,879,000	—	30 Sep 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.71%	840,284	$14,596,000	—	30 Sep 2017	13F
Granite Investment Partners, LLC	13F	Company	0.69%	818,505	$14,217,000	—	30 Sep 2017	13F
Rubric Capital Management LP	13F	Company	0.66%	783,000	$13,601,000	—	30 Sep 2017	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.66%	781,691	$13,578,000	—	30 Sep 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.63%	741,437	$12,879,000	—	30 Sep 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.54%	635,468	$11,035,000	—	30 Sep 2017	13F
Fisher Asset Management, LLC	13F	Company	0.49%	583,221	$10,131,000	—	30 Sep 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.48%	570,513	$9,910,000	—	30 Sep 2017	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.48%	565,529	$9,823,000	—	30 Sep 2017	13F
MORGAN STANLEY	13F	Company	0.47%	560,868	$9,742,000	—	30 Sep 2017	13F
MACQUARIE GROUP LTD	13F	Company	0.42%	500,000	$8,685,000	—	30 Sep 2017	13F
First Light Asset Management, LLC	13F	Company	0.38%	445,846	$7,744,000	—	30 Sep 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.38%	445,769	$7,743,000	—	30 Sep 2017	13F
D. E. Shaw & Co., Inc.	13F	Company	0.32%	377,356	$6,555,000	—	30 Sep 2017	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.31%	365,394	$6,347,000	—	30 Sep 2017	13F
ORBIMED ADVISORS LLC	13F	Company	0.3%	350,000	$6,080,000	—	30 Sep 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.27%	323,388	$5,618,000	—	30 Sep 2017	13F
SEI INVESTMENTS CO	13F	Company	0.27%	322,262	$5,598,000	—	30 Sep 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.27%	315,162	$5,474,000	—	30 Sep 2017	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.24%	282,633	$4,907,000	—	30 Sep 2017	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.23%	275,939	$4,793,000	—	30 Sep 2017	13F
CREDIT SUISSE AG/	13F	Company	0.23%	275,458	$4,784,000	—	30 Sep 2017	13F
State of New Jersey Common Pension Fund D	13F	Company	0.22%	255,000	$4,429,000	—	30 Sep 2017	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.21%	250,000	$4,343,000	—	30 Sep 2017	13F
CASTLEARK MANAGEMENT LLC	13F	Company	0.2%	232,905	$4,046,000	—	30 Sep 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.19%	221,194	$3,842,000	—	30 Sep 2017	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.18%	213,429	$3,707,000	—	30 Sep 2017	13F

Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q4 2017

As of 31 Dec 2017, HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by 196 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,499,248 shares. The largest 10 holders included Third Security, LLC, BlackRock Inc., Vanguard Group Inc, IRIDIAN ASSET MANAGEMENT LLC/CT, BB BIOTECH AG, First Eagle Investment Management, LLC, Invesco Ltd., STATE STREET CORP, FMR LLC, and JPMORGAN CHASE & CO. This page lists 196 institutional shareholders reporting positions in this security for the Q4 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders

164

Q4 2017 holders

196

Holder diff

Investor	Q3 2017 Shares	Q4 2017 Shares	Share Diff	Share Chg %	Q3 2017 Value $	Q4 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.